Rgenix is Drug Discovery in United States that focus on tumor growth business. Founded in 2010. They cover business area such as developer, novel cancer drug, key pathway, cancer progression, novel cancer target, cancer patient, optimal cure, small molecule, antibody.
2010
( 16 years old in 2026 )
Tumor Growth
-
310 East 67th Street
Suite 1-12
New York, NY 10065
United States
Private
developernovel cancer drugkey pathwaycancer progressionnovel cancer targetcancer patientoptimal curesmall moleculeantibody
* We use standard office opening hours in near Rgenix's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Rgenix is Drug Discovery business from United States that founded in 2010 (16 years old in 2026), Rgenix business is focusing on Tumor Growth.
Rgenix headquarter office and corporate office address is located in 310 East 67th Street Suite 1-12 New York, NY 10065 United States.
Rgenix was founded in United States.
In 2026, Rgenix is currently focus on tumor growth sector.
Above is snippet of Google Trends for "tumor growth" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Rgenix, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
